大众医学与个性化医学:从数学方法到监管影响
Inderpal S Randhawa1, Grigori Sigalov1
1Food Allergy Institute, Long Beach, CA, United States.
人工智能 (AI) 可以通过分析临床试验中的受试者变异性来增强传统医学. 这种个性化医疗方法改善了对个体患者的治疗成功预测,而不仅仅是群体.
科学领域:
- 医学研究 医学研究
- 人工智能的人工智能
- 个性化医疗是个性化的医疗.
背景情况:
- 传统的临床试验证明了群体的有效性,假设患者的反应均.
- 标准的统计方法估计了平均效应,但无法预测个体患者的结果.
- 在小组分析中,主体变异性往往被忽视,这阻碍了个性化治疗预测.
研究的目的:
- 展示人工智能 (AI) 在改善传统大众医学的治疗成功估计方面的潜力.
- 要突出AI驱动的个性化医学如何利用现有的临床试验数据对受试者的变化.
- 争取人工智能在医学实践中超越罕见疾病的更广泛应用.
主要方法:
- 利用由先进的数学方法和人工智能驱动的多变量预测模型.
- 将受试者的变化直接纳入预测模型,以提高准确性和选择性.
- 分析和解释现有的临床试验数据以使用个性化医疗方法对受试者变异性的分析和解释.
主要成果:
- 人工智能使个性化医学能够根据个体患者的独特特征预测预期的治疗效果.
- 人工智能可以提高大众医学的治疗成功估计的准确性和选择性,而无需额外的研究成本.
- 现有的临床试验数据可以重新分析对象变异性,以获得个性化的见解.
结论:
- 人工智能驱动的个性化医疗比传统的基于小组的疗效评估有了显著的进步.
- 将人工智能集成到临床数据分析中可以完善个体患者的治疗策略.
- 像FDA这样的机构的监管承认对于在临床实践中实施人工智能驱动的个性化医疗至关重要.
更多相关视频
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
04:24Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
Published on: June 16, 2023
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis of Population Pharmacokinetic Data
Fundamental Mathematical Principles in Pharmacokinetics: Mathematical Expressions and Units
One significant application of mathematics in pharmacokinetics is the characterization of drug distribution through the volume of distribution...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
